Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial

  • Jenna H. Rannikko
  • , Loic Verlingue
  • , Maria de Miguel
  • , Annika Pasanen
  • , Debbie Robbrecht
  • , Tanja Skytta
  • , Sanna Iivanainen
  • , Shishir Shetty
  • , Yuk Ting Ma
  • , Donna M. Graham
  • , Sukeshi Patel Arora
  • , Panu Jaakkola
  • , Christina Yap
  • , Yujuan Xiang
  • , Jami Mandelin
  • , Matti K. Karvonen
  • , Juho Jalkanen
  • , Sinem Karaman
  • , Jussi P. Koivunen
  • , Anna Minchom
    • Maija Hollmén, Petri Bono

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science